Status:
UNKNOWN
Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
Lead Sponsor:
Instituto Nacional de Cardiologia Ignacio Chavez
Conditions:
Acute Kidney Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether sodium bicarbonate is effective in the prevention of sodium-induced nephropathy
Detailed Description
The use of contrast media is more frequent as new diagnostic and therapeutic procedures are developed. As a consequence, the occurrence of acute renal failure (ARF), also known as contrast-induced nep...
Eligibility Criteria
Inclusion
- Age over 18 years old
- Indication for coronariography and/or percutaneous coronary intervention
- Voluntary written consent for the realization of coronariography and/or percutaneous intervention and for the participation in this clinical trial
- A MEHRAN contrast-induced nephropathy score of six or more
Exclusion
- Patients with chronic kidney failure requiring any kind of dialysis
- Patients unable to complete follow-up
- Multiple myeloma
- Exposure to contrast 48 hours prior to study
- Pregnancy
- Patients unable to give consent
- Already receiving sodium bicarbonate solutions
- Receiving contrast media other than non-ionic
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00424320
Start Date
October 1 2006
End Date
January 1 2007
Last Update
January 19 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
ABC Medical Center
Mexico City, Mexico City (d.f.), Mexico, 01120
2
Ignacio Chávez National Institute of Cardiology
Mexico City, Mexico City (d.f:), Mexico, 14080